These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1414157)

  • 1. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse.
    Nara N; Tohda S; Suzuki T; Nagata K; Tanikawa S; Imai Y; Tomiyama J; Shiina S
    Acta Haematol; 1992; 88(1):17-21. PubMed ID: 1414157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro growth patterns and drug sensitivities of leukemic blast progenitors among the subtypes of acute myelocytic leukemia.
    Nara N; Chen GJ; Murohashi I; Tohda S; Imai Y; Tomiyama J; Nagata K; Suzuki T; Tanikawa S; Shiina S
    Exp Hematol; 1992 Aug; 20(7):904-8. PubMed ID: 1628709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the in vitro sensitivity to cytosine arabinoside of blast progenitors and the outcome of treatment in acute myeloblastic leukaemia patients.
    Nara N; Suzuki T; Nagata K; Yamashita Y; Murohashi I; Adachi Y
    Br J Haematol; 1988 Oct; 70(2):187-91. PubMed ID: 3191030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
    Nara N
    Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the blast self-renewal capacity in patients with acute myeloid leukemia.
    Nara N; Kurokawa H; Tanikawa S; Tomiyama J; Nagata K
    Cancer; 1994 Jan; 73(1):92-7. PubMed ID: 8275443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human tumor necrosis factor on the self-renewal capacity of leukemia blast progenitors in acute myeloblastic leukemia.
    Nagata K; Tohda S; Suzuki T; Nara N
    Leukemia; 1989 Sep; 3(9):626-30. PubMed ID: 2761317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.
    Nara N; Suzuki T; Yamashita Y; Murohashi I; Aoki N
    Cancer Res; 1988 May; 48(9):2348-52. PubMed ID: 3162711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
    Cannistra SA; Groshek P; Griffin JD
    Leukemia; 1989 May; 3(5):328-34. PubMed ID: 2654494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the lethal effects in culture of cytosine arabinoside and arabinofuranosyl-5-azacytosine acting on the blast cells fo acute myeloblastic leukemia.
    Yang GS; McCulloch EA
    Hematol Pathol; 1992; 6(3):125-30. PubMed ID: 1385380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human D-factor on the growth of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Chen GJ; Tomida M; Hozumi M; Nara N
    Jpn J Cancer Res; 1992 Dec; 83(12):1341-6. PubMed ID: 1282910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.
    Pinto A; Aldinucci D; Gattei V; Zagonel V; Tortora G; Budillon A; Cho-Chung YS
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8884-8. PubMed ID: 1329084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia.
    Nara N; Curtis JE; Senn JS; Tritchler DL; McCulloch EA
    Blood; 1986 Mar; 67(3):762-9. PubMed ID: 3456247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of humoral and cellular factors on the growth of blast progenitors of acute myeloblastic leukemia in serum-free culture.
    Maruyama Y; Tohda S; Nagata K; Suzuki T; Murohashi I; Nara N
    Hematol Pathol; 1990; 4(3):115-23. PubMed ID: 1701766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TNFalpha on the growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia with special reference to the role of NF-kappaB.
    Wu Z; Shen L; Inatomi Y; U M; Miyashita T; Toyama K; Miyauchi J
    Leuk Res; 2003 Nov; 27(11):1009-18. PubMed ID: 12859994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
    Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
    J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of melphalan against self-renewal capacity of leukemic progenitors in acute myeloblastic leukemia.
    Demur C; Chiron M; Saivin S; Attal M; Dastugue N; Bousquet C; Galinier JL; Colombies P; Laurent G
    Leukemia; 1992 Mar; 6(3):204-8. PubMed ID: 1564957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta).
    Nara N; Tohda S; Nagata K; Suzuki T; Yamashita Y
    Leukemia; 1989 Aug; 3(8):572-7. PubMed ID: 2473359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of drug resistance in cultured clonogenic leukemic blast cells during the clinical course of myeloblastic leukemia.
    Asano Y; Okamura S; Shibuya T; Morioka E; Hirota Y; Niho Y
    Oncology; 1989; 46(5):339-42. PubMed ID: 2779949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia.
    Nara N; Tanikawa S; Nagata K; Hamaguchi H; Tomiyama J
    Int J Hematol; 1993 Aug; 58(1-2):27-35. PubMed ID: 7693028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2.
    Hedley DW; McCulloch EA
    Leukemia; 1996 Jul; 10(7):1143-9. PubMed ID: 8683994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.